B.Riley reiterates Buy on IonQ stock, $100 target on revenue boost

IonQ raised fiscal 2026 revenue guidance to $450 million-$460 million, a midpoint increase of $170 million from $285 million, including four months of acquired SkyWater Technology revenue. B. Riley reiterated its Buy rating and $100 price target, estimating a further 5%-7% upside to 2026 revenue and suggesting annualized revenue could approach $1 billion over the next four quarters. IonQ shares rose 11% in early trading after the company also announced pre-orders for its 256-qubit Superion system; its most recent quarter delivered $80.05 million in revenue versus $65.4 million consensus and a narrower-than-expected $0.33 per-share loss.

Analysis

The key valuation question is not the higher top-line trajectory but the quality of that revenue: the acquired fabrication business likely carries a materially different gross-margin, capex, and working-capital profile than a quantum-computing software/services narrative. Unless management provides pro-forma segment revenue, backlog conversion, gross margin, and capital-intensity targets, the market risks capitalizing acquired foundry revenue at a quantum-premium multiple. That creates a 1-3 month de-rating risk even if reported revenue continues to beat.

The investor-day catalyst is likely binary because pre-orders are not equivalent to funded bookings or recognized revenue. A credible disclosure of customer deposits, cancellation terms, delivery timelines, and post-integration margin targets would support a higher estimate base; vague technical milestones would leave the stock exposed to profit-taking after the sharp rebound. Newly registered shares and acquisition consideration also create an incremental supply overhang, particularly if legacy SkyWater holders view IONQ as a less natural holding.

Contrarianly, the combination could make IONQ more commercially relevant than pure-play quantum peers if it can control chip fabrication, packaging, and customer qualification cycles. That upside requires evidence that vertical integration improves quantum-system unit economics rather than simply adding lower-multiple semiconductor revenue. The relevant 6-18 month differentiator is repeatable commercial deployments, not qubit count or announced availability.

Key Decisions for Investors

• Do not chase the post-event move in IONQ before management discloses pro-forma 2027 gross-margin and capex targets, organic versus acquired revenue, and funded backlog. Treat absence of these metrics as a signal to reduce exposure; the principal risk is multiple compression rather than an immediate revenue miss.
• For existing IONQ longs, buy 1-3 month, 10-15% out-of-the-money puts around the investor-day/next-results window. This offers defined downside protection against a "sell-the-news" reversal and incremental share-supply pressure while preserving upside if commercial booking data validates the bull case.
• Use a conditional pair trade only if IONQ provides verifiable margin and backlog evidence: long IONQ / short QBTS in equal beta-adjusted dollars over the next 3-6 months. The thesis is that integrated manufacturing could differentiate execution; exit if IONQ fails to demonstrate organic bookings or lowers post-acquisition margin expectations.
• Set an alert for a guidance raise driven primarily by additional acquisition contribution, rather than organic quantum revenue. That would falsify the vertical-integration premium thesis and favor an outright tactical short or reduction in IONQ exposure.